000 01497 a2200433 4500
005 20250517041713.0
264 0 _c20160727
008 201607s 0 0 eng d
022 _a1873-7560
024 7 _a10.1016/j.eururo.2015.06.039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGartrell, Benjamin A
245 0 0 _aMetastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
_h[electronic resource]
260 _bEuropean urology
_cNov 2015
300 _a850-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aDenosumab
_xtherapeutic use
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFractures, Spontaneous
_xprevention & control
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xpathology
650 0 4 _aRadioisotopes
_xtherapeutic use
650 0 4 _aRadium
_xtherapeutic use
650 0 4 _aZoledronic Acid
700 1 _aColeman, Robert
700 1 _aEfstathiou, Eleni
700 1 _aFizazi, Karim
700 1 _aLogothetis, Christopher J
700 1 _aSmith, Matthew R
700 1 _aSonpavde, Guru
700 1 _aSartor, Oliver
700 1 _aSaad, Fred
773 0 _tEuropean urology
_gvol. 68
_gno. 5
_gp. 850-8
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2015.06.039
_zAvailable from publisher's website
999 _c25053907
_d25053907